ProQR Therapeutics (PRQR) Cash from Investing Activities Growth (1y) (2014 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 110.21% |
| Sep 30, 2022 | -20.19% |
| Jun 30, 2022 | -293.62% |
| Mar 31, 2022 | -609.47% |
| Dec 31, 2021 | -34.98% |
| Sep 30, 2021 | 33.08% |
| Jun 30, 2021 | 83.47% |
| Mar 31, 2021 | -17,559.24% |
| Dec 31, 2020 | 46.82% |
| Sep 30, 2020 | -766.04% |
| Jun 30, 2020 | -292.10% |
| Mar 31, 2020 | 99.91% |
| Dec 31, 2019 | -858,322.67% |
| Sep 30, 2019 | 69.08% |
| Jun 30, 2019 | 55.51% |
| Mar 31, 2019 | -5,158,046.10% |
| Dec 31, 2018 | -361.74% |
| Sep 30, 2018 | -544,514.13% |
| Jun 30, 2018 | -311.55% |
| Mar 31, 2018 | -89.75% |
| Dec 31, 2017 | 100.00% |
| Sep 30, 2017 | 104.49% |
| Dec 31, 2016 | -88.87% |
| Sep 30, 2016 | -656.21% |
| Dec 31, 2015 | -81.56% |
| Sep 30, 2015 | 99.99% |
| Mar 31, 2015 | -157.91% |
| Dec 31, 2014 | -584.93% |
| Sep 30, 2014 | -101.51% |